Issues
- PDF Icon PDF LinkFront Matter
- PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkBack Matter
- PDF Icon PDF LinkAdvertising
- PDF Icon PDF LinkEditorial Board
Cancer Research
Table of Contents
Articles
Induction of Cancer, Actinic Keratosis, and Specific p53 Mutations by UVB Light in Human Skin Maintained in Severe Combined Immunodeficient Mice1
Medulloblastomas of the Desmoplastic Variant Carry Mutations of the Human Homologue of Drosophila patched1
Association between Cigarette Smoking and FHIT Gene Alterations in Lung Cancer1
Cloning and Characterization of Mammalian 8-Hydroxyguanine-specific DNA Glycosylase/Apurinic, Apyrimidinic Lyase, a Functional mutM Homologue1
Studies on the Metabolism of the Novel Antitumor Agent [N-methyl-11C]N-[2-(dimethylamino)ethyl]acridine-4-carboxamide in Rats and Humans prior to Phase I Clinical Trials1
Enhanced Induction of Very Late Antigen 4/Lymphocyte Function-associated Antigen 1-dependent T-Cell Migration to Tumor Sites following Administration of Interleukin 121
Allelic Deletions on Chromosome 11q13 in Multiple Endocrine Neoplasia Type 1-associated and Sporadic Gastrinomas and Pancreatic Endocrine Tumors
FHIT and FRA3B 3p14.2 Allele Loss Are Common in Lung Cancer and Preneoplastic Bronchial Lesions and Are Associated with Cancer-related FHIT cDNA Splicing Aberrations1
Journal Archive
Cancer Research
(1941-Present; volumes 1-current)Published twice monthly since 1987. From 1941-1986, published monthly.
(ISSN 0008-5472)
The American Journal of Cancer
(1931-1940; volumes 15-40)Published quarterly in 1931, bimonthly in 1932, and monthly from 1933 to 1940. The journal changed title to Cancer Research in 1941.
(ISSN 0099-7374)
The Journal of Cancer Research
(1916-1930); volumes 1-14)Published quarterly from 1916 through 1930 (publication was suspended from November 1922 to March 1924). The journal changed title to The American Journal of Cancer in 1931.
(ISSN 0099-7013)
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio® (avelumab), a pharmaceutical owned by Merck. None of these funds are being, or will be, used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.
RSS Feeds